AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitenali M 50mg/1000mg Tablet

Prescription Icon
Prescription Required

Marketer

Cadila Pharmaceuticals Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Sitenali M 50mg/1000mg Tablet

Combiflex DM 50mg/1000mg tablets contain a dual-action formula managing elevated blood glucose in type 2 diabetes patients. This helps mitigate severe diabetic complications like renal impairment and vision loss, potentially lessening heart attack or stroke risk. Combiflex DM 50mg/1000mg tablets can be used independently or in conjunction with other antidiabetic therapies. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is personalized based on your health status, glucose readings, and other medications. Consuming it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes benefits; discontinuation should only occur under your physician's guidance. Maintaining your prescribed diet and exercise regimen is crucial for effective diabetes control; lifestyle choices significantly impact management. Common adverse effects include diarrhea, nausea, vomiting, indigestion, headache, and pharyngitis. Hypoglycemia is a potential risk, particularly when combined with insulin or sulfonylureas; learn its symptoms and management. This medication isn't universally suitable. Inform your doctor of prior kidney, liver, or heart conditions, pancreatic issues, or excessive alcohol consumption before commencing treatment. Pregnant or lactating individuals must seek medical counsel. Interactions with other medications exist; disclose all your current medications to ensure safety. Alcohol should be limited due to its hypoglycemic effects. Your doctor will monitor your renal function and blood sugar levels throughout treatment.

Primary Ingredients of Sitenali M 50mg/1000mg Tablet

No text provided. Please provide the text you wish me to rephrase.

Uses of Sitenali M 50mg/1000mg Tablet

Managing type 2 diabetes

Major Benefits of Sitenali M 50mg/1000mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Sitenali M 50mg/1000mg tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

Common Side effects of Sitenali M 50mg/1000mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitenali M 50mg/1000mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the Sitenali M 50mg/1000mg tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

How Sitenali M 50mg/1000mg Tablet works:

Sitenali M, a 50mg/1000mg tablet, combines sitagliptin and metformin to manage blood glucose. Sitagliptin boosts insulin production from the pancreas, improves insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, decreases liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitenali M 50mg/1000mg Tablet with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitenali M 50mg/1000mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Medical advice is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

There is likely a risk associated with using Sitenali M 50mg/1000mg tablets while breastfeeding. Preliminary evidence indicates potential transfer of the medication into breast milk, posing a possible threat to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitenali M 50mg/1000mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Sitenali M 50mg/1000mg tablets. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

Individuals with liver impairment should likely avoid Sitenali M 50mg/1000mg Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sitenali M 50mg/1000mg Tablet :

Should you forget to take your Sitenali M 50mg/1000mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitenali M 50mg/1000mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitenali M 50mg/1000mg Tablet

Sitenali M 50mg/1000mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is unsuitable for individuals under 18.
Prolonged use of Sitenali M 50mg/1000mg Tablet can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitenali M 50mg/1000mg tablets may cause common side effects such as low blood sugar, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitenali M 50mg/1000mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Sitenali M 50mg/1000mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin 50mg/1000mg can cause lactic acidosis, a serious, potentially fatal buildup of lactic acid in the blood (also known as MALA). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Sitenali M 50mg/1000mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This treatment improves blood sugar control when combined with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This combination is unsuitable for individuals under 18.
Sitenali M 50mg/1000mg tablets may cause common side effects including low blood sugar, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis can occur. Prolonged use may also result in vitamin B12 deficiency.
Patients with allergies to Sitenali M 50mg/1000mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitenali M 50mg/1000mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin 50mg/1000mg tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). While rare, this risk is higher in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, stop taking Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitenali M 50mg/1000mg Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia and neurological issues, manifesting as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitenali M 50mg/1000mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitenali M 50mg/1000mg tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients allergic to Sitenali M 50mg/1000mg Tablet components or excipients, or with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Sitenali M 50mg/1000mg Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (like Sitenali M 50mg/1000mg) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA). This rare side effect necessitates caution in patients with kidney disease, older adults, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitenali M 50mg/1000mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; ensure it remains inaccessible to children, pets, and others.
Sitenali M 50mg/1000mg Ta...
231